A detailed history of Beacon Financial Advisory LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Beacon Financial Advisory LLC holds 446 shares of VRTX stock, worth $224,092. This represents 0.08% of its overall portfolio holdings.

Number of Shares
446
Previous 434 2.76%
Holding current value
$224,092
Previous $203,000 1.97%
% of portfolio
0.08%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$460.0 - $505.78 $5,520 - $6,069
12 Added 2.76%
446 $207,000
Q2 2024

Jul 26, 2024

BUY
$392.81 - $485.53 $170,479 - $210,720
434 New
434 $203,000
Q4 2023

Jan 23, 2024

BUY
$343.0 - $410.68 $175,616 - $210,268
512 New
512 $208,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Beacon Financial Advisory LLC Portfolio

Follow Beacon Financial Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Financial Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Financial Advisory LLC with notifications on news.